>>> Cellink AB (CLLKF) designs and develops bioprinting technologies that enable researchers to 3D print organs and tissue for applications primarily in pharmaceutical to cosmetic industries worldwide. It offers bioprinters, imaging systems, dispensing solutions, and bioinks in the field of academic and clinical medicine for labs and scientists worldwide. The company's bioprinting solutions include BIO X, a bioprinter for life-science companies, researchers, and innovators; BIO X6, a bioprinting platform for printing complex structures; INKREDIBLE and INKREDIBLE+, which are bioprinting solutions for skin, cartilage tissue, and others; Holograph X, a solution that leverages high-resolution holographic stereolithography to bioprint small structures; Lumen X, a solution that offers applications in microfluidics, cell-laden hydrogels, macroporous structures, and others; and tool heads and print heads. It also offers biofluidics solutions, which include I-DOT, a solution for liquid-handling tasks; single-cell printer, an automated laboratory instrument; c.sight, a single-cell dispensing technology for cell line development and single-cell genomics; b.sight, a solution that enables prokaryotic cell isolation in the sub-micron range; and f.sight, a solution that dispenses unlabeled and fluorescent cells. The company offers bioinks for various applications, such as drug screening, tissue models, tissue regeneration, organoids, immunotherapy, microfluidics, scaffolds, encapsulation, wound healing, cosmetics, educational models, and others; CELLCYTE X, a live cell microscopy imaging system; and accessories, such as consumables, needles, and nozzles. Its customers also include universities, hospitals, and public and commercial laboratories. Cellink AB (publ) has a collaboration with MedImmune; and strategic partnership with Made In Space, Inc. It also offers products online. The company was founded in 2016 and is based in Gothenburg, Sweden.
<<<
